Shandong Weigao reduces H shares through August repurchases

Shandong Weigao Group Medical Polymer Company Limited reported a reduction in its total issued H shares by 2,158,800 during August 2025, according to its latest monthly return. The company repurchased H shares on two occasions: 898,800 shares on August 28, 2025, at an average price of HK$5.8758, and 1,260,000 shares on August 29, 2025, at an average price of HK$5.911.

As a result of these repurchases, the number of issued H shares (excluding treasury shares) decreased from 4,513,522,724 to 4,511,363,924. Correspondingly, the number of H shares held as treasury shares increased by the same amount, rising from 8,809,600 to 10,968,400.

The total authorized/registered share capital at the end of August 2025 remained unchanged at RMB 457,063,232.4. This figure comprises RMB 452,233,232.4 from H shares and RMB 4,830,000 from non-listed shares.